Skip to main content
PMC home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1972 Apr 8;106(7):770–775.

Phenacetin-induced hemolytic anemia

John Millar, Robert Péloquin, Nannie K M de Leeuw
PMCID: PMC1940540  PMID: 5016923

Abstract

The hematological features of phenacetin-induced hemolytic anemia are presented in order to make the physician aware of the abnormalities which suggest the use of an oxidant drug. The presence of “bitten out” red cells is the commonest initial clue to the existence of drug-induced hemolytic anemia. The diagnosis is confirmed by the demonstration of Heinz bodies and sulfhemoglobinemia. Early recognition of this form of drug-abuse may avert the development or progression of analgesic nephropathy.

Full text

PDF
770

Images in this article

772FIG. 2
on p.772

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALLEN D. W., JANDL J. H. Oxidative hemolysis and precipitation of hemoglobin. II. Role of thiols in oxidant drug action. J Clin Invest. 1961 Mar;40:454–475. doi: 10.1172/JCI104273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beutler E. Drug-induced hemolytic anemia. Pharmacol Rev. 1969 Mar;21(1):73–103. [PubMed] [Google Scholar]
  3. Beutler E., Mitchell M. Special modifications of the fluorescent screening method for glucose-6-phosphate dehydrogenase deficiency. Blood. 1968 Nov;32(5):816–818. [PubMed] [Google Scholar]
  4. DAUSSET J., CONTU L. A CASE OF HAEMOLYTIC ANAEMIA DUE TO PHENACETIN ALLERGY. Vox Sang. 1964 Sep-Oct;9:599–607. doi: 10.1111/j.1423-0410.1964.tb03330.x. [DOI] [PubMed] [Google Scholar]
  5. Dawborn J. K., Fairley K. F., Kincaid-Smith P., King W. E. The association of peptic ulceration, chronic renal disease, and analgesic abuse. Q J Med. 1966 Jan;35(137):69–83. [PubMed] [Google Scholar]
  6. Dimitrov N. V., Miller J., Ziegra S. R. The effects of caffeine on glucose metabolism of polymorphonuclear leukocytes. J Pharmacol Exp Ther. 1969 Aug;168(2):240–243. [PubMed] [Google Scholar]
  7. FRIIS T., FOGH J., NISSEN N. I. The mechanism of reduction of erythrocyte lifetime in phenacetin habitues with renal impairment. Acta Med Scand. 1960 Oct 17;168:127–131. doi: 10.1111/j.0954-6820.1960.tb06653.x. [DOI] [PubMed] [Google Scholar]
  8. Gault M. H., Rudwal T. C., Engles W. D., Dossetor J. B. Syndrome associated with the abuse of analgesics. Ann Intern Med. 1968 Apr;68(4):906–925. doi: 10.7326/0003-4819-68-4-906. [DOI] [PubMed] [Google Scholar]
  9. JANDL J. H., ENGLE L. K., ALLEN D. W. Oxidative hemolysis and precipitation of hemoglobin. I. Heinz body anemias as an acceleration of red cell aging. J Clin Invest. 1960 Dec;39:1818–1836. doi: 10.1172/JCI104206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jacob H. S., Jandl J. H. Effects of sulfhydryl inhibition on red blood cells. 3. Glutathione in the regulation of the hexose monophosphate pathway. J Biol Chem. 1966 Sep 25;241(18):4243–4250. [PubMed] [Google Scholar]
  11. KUNKEL H. G., CEPPELLINI R., MULLER-EBERHARD U., WOLF J. Observations on the minor basic hemoglobin component in the blood of normal individuals and patients with thalassemia. J Clin Invest. 1957 Nov;36(11):1615–1625. doi: 10.1172/JCI103561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. LORENZEN I., SCHWARTZ M. Phenacetin-induced haemolysis in patients with chronic nephritis and phenacetin abuse. Acta Med Scand. 1960 Dec 20;168:461–466. doi: 10.1111/j.0954-6820.1960.tb06678.x. [DOI] [PubMed] [Google Scholar]
  13. MACGIBBON B. H., LOUGHRIDGE L. W., HOURIHANE D. O., BOYD D. W. Autoimmune haemolytic anaemia with acute renal failure due to phenacetin and p-aminosalicylic acid. Lancet. 1960 Jan 2;1(7114):7–10. doi: 10.1016/s0140-6736(60)92714-8. [DOI] [PubMed] [Google Scholar]
  14. MUIRHEAD E. E., HALDEN E. R., GROVES M. Drug-dependent Coombs (antiglobulin) test and anemia; observations on quinine and acetophenetidin (phenacetin). AMA Arch Intern Med. 1958 Jan;101(1):87–96. doi: 10.1001/archinte.1958.00260130101010. [DOI] [PubMed] [Google Scholar]
  15. NISSEN N. I., FRIIS T. Further study of the mechanism of reduction of erythrocyte survival time in phenacetin habitues and its relation to "phenacetin kidney disorders". Acta Med Scand. 1962 Feb;171:125–134. doi: 10.1111/j.0954-6820.1962.tb04173.x. [DOI] [PubMed] [Google Scholar]
  16. Necheles T. F., Allen D. M. Current concepts: Heinz-body anemias. N Engl J Med. 1969 Jan 23;280(4):203–206. doi: 10.1056/NEJM196901232800406. [DOI] [PubMed] [Google Scholar]
  17. Rifkind R. A. Destruction of injured red cells in vivo. Am J Med. 1966 Nov;41(5):711–723. doi: 10.1016/0002-9343(66)90032-5. [DOI] [PubMed] [Google Scholar]
  18. Shelley J. H. Phenacetin, through the looking glass. Clin Pharmacol Ther. 1967 May-Jun;8(3):427–471. doi: 10.1002/cpt196783427. [DOI] [PubMed] [Google Scholar]
  19. de LEEUW N., SHAPIRO L., LOWENSTEIN L. Drug-induced hemolytic anemia. Ann Intern Med. 1963 Apr;58:592–607. doi: 10.7326/0003-4819-58-4-592. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES